Postdoctoral positions at Rutgers Cancer Institute, Rutgers University-State University of New Jersey (New Brunswick campus) are available immediately. The research interest of the lab is to study the molecular mechanisms of cancer metabolic reprogramming, tumor microenvironment shaping, cancer immunology, tumor suppressor (including p53 and Parkin) signaling pathways.
Some related recent publications: Cell Rep Med: 2026:102704.
Nature Communications, 2025, 16(1), 1762; 2024, 15(1):627; 2024, 15(1):137; 2021, 12:3371; 2017, 8:1823
J Clin Invest: 2023, e164354; and 2020, 130:3253. Blood: 2022; 140:2076. Nature Metabolism: 2022, 4:1830. Genes Development: 30:1956; and 31: 1641. PNAS, 108(39):16259; and 107(16):7455; Cell Death Differ. 22(11):1824;and 21(11):1792. More information regarding the lab is available at:
Candidates with strong backgrounds and skills in molecular biology and/or cancer biology are welcome. Rutgers Cancer Institute of New Jersey/Rutgers University (New Brunswick campus) is a National Health Institute (NIH)/National Cancer Institute (NCI) designated comprehensive cancer center. Rutgers Cancer Institute of New Jersey offers a highly collaborative scientific andfriendly environment as well as a competitive salary and benefit. The campus is within a short distance from New York City, Philadelphia, and several major international airports. For more information, please visit
Applicants should send a CV by email to: Professor Zhaohui Feng, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA. E-mail: fengzh@cinj.rutgers.edu